US FDA staff questions confirmatory trial data for Intercept's liver disease drug

[cafead]

via Staff reviewers at the U.S. Food and Drug Administration said on Wednesday a confirmatory trial did not show the effectiveness of Intercept's liver disease drug, which received the health regulator's accelerated nod in 2016.

article source